Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition

Diabetes Care

Volumn 24, Issue 7, 2001, Pages 1240-1247

  Hanley, Anthony J G ^a,b   Mckeown Eyssen, Gail ^a   Harris, Stewart B ^c   Regele, Robert A ^d   Wolever, Thomas M S ^a   Kwan, Jeremy ^a   Connelly, Philip W ^e   Zinman, Bernard ^b,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ROBARTS RESEARCH INSTITUTE   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; C PEPTIDE; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROINSULIN; TRIACYLGLYCEROL;

ADULT; AMERICAN INDIAN; ARTICLE; BLOOD; BLOOD PRESSURE; CANADA; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; APOLIPOPROTEINS; APOLIPOPROTEINS B; BLOOD PRESSURE; C-PEPTIDE; CANADA; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIANS, NORTH AMERICAN; LIPIDS; MALE; PROINSULIN; PROSPECTIVE STUDIES; RISK FACTORS; TRIGLYCERIDES;

EID: 0035408380     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.7.1240     Document Type: Article

References (12)

1. Geiss LS, Herman WH, Smith PJ: Mortality in non-insulin dependent diabetes mellitus. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Washington, DC, U.S. Govt. Printing Office, 1995, p. 233-257 (NIH publ. no. 95-1468)
2. Cowie CC, Harris MI: Physical and metabolic characteristics of persons with diabetes. In Diabetes in America. 2nd ed. National Diabetes Data Group, Ed. Wash-ington, DC, U.S. Govt. Printing Office, 1995, p. 117-164 (NIH publ. no. 95-1468)
3. Meigs JB, Nathan DM, Wilson PWF, Cupples A, Singer DE: Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance: the Framingham Offspring Study. Ann Intern Med 128:524-533, 1998
4. Alberti KGMM: The clinical implications of impaired glucose tolerance. Diabet Med 13:927-937, 1996
5. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
6. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
7. Despres J-P, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
8. Mitchell BD, Haffner SM, Hazuda HP, Valdez R, Stem P: The relation between serum insulin levels and 8-year changes in lipid, lipoprotein and blood pressure levels. Am J Epidemiol 136:12-22, 1992
9. Garg A: Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 19:387-389, 1996
10. Jarrett RJ: Why is insulin not a risk factor for coronary heart disease? Diabetologia 37:945-947, 1994
11. Temple RC, Carrington CA, Luzio SD, Owens DR, Schneider AE, Sobey WJ, Hales CN: Insulin deficiency in non-insulin-dependent diabetes. Lancet 1:293-295, 1989
12. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y: Serum proinsulin levels at fasting and after oral glucose load in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 31:355-360, 1988